Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome

Circulation Journal

Volumn 76, Issue 4, 2012, Pages 778-783

  Reriani, Martin K ^a   Flammer, Andreas J ^a   Jama, Abdi ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a Mayo Clinic   (United States)

Author keywords

Acute coronary syndrome; Endothelial dysfunction; Endothelium; Therapeutic endpoint; Vascular health

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FRAMINGHAM RISK SCORE; HEART DISEASE; HEART INFARCTION; HUMAN; MENTAL STRESS; MORTALITY; PREDICTION; PROGNOSIS; RISK ASSESSMENT; SLEEP APNEA SYNDROME; TONOMETRY;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASES; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; HUMANS; MYOCARDIUM; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SLEEP APNEA SYNDROMES; STRESS, PSYCHOLOGICAL; VULNERABLE POPULATIONS;

EID: 84858983984     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0248     Document Type: Article

References (83)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: Heart disease and stroke statistics 2010 update: A report from the american heart association. Circulation 2010; 121: 948-954.
2. Lloyd-Jones DM, Camargo CA, Allen LA, Giugliano RP, O'Donnell CJ. Predictors of long-term mortality after hospitalization for primary unstable angina pectoris and non-st-elevation myocardial infarction. Am J Cardiol 2003; 92: 1155-1159.
3. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-1504.
4. Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents. JAMA 2008; 299: 2868-2876.
5. Mauri L, Silbaugh TS, Garg P, Wolf RE, Zelevinsky K, Lovett A, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008; 359: 1330-1342.
6. Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: Temporal changes, characteristics, and 1-year outcome. Am Heart J 2007; 154: 1108-1115.
7. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: Estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727-2733.
8. Furman MI, Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial q-wave and non-q-wave myocardial infarction: A multi-hospital, community-wide perspective. J Am Coll Cardiol 2001; 37: 1571-1580.
9. Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, et al. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA 2011; 306: 2120-2127.
10. Roe MT, Halabi AR, Mehta RH, Chen AY, Newby LK, Harrington RA, et al. Documented traditional cardiovascular risk factors and mortality in non-st-segment elevation myocardial infarction. Am Heart J 2007; 153: 507-514.
11. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, et al. Predictive accuracy of the Framingham coronary risk score in British men: Prospective cohort study. BMJ 2003; 327: 1267.
12. Wong J, Wong V, Fahey T, Brindle P, Hay A. Predictors of postmenopausal osteoporosis: Study methods and analysis require clarification. BMJ 2003; 327: 392; author reply 392-393.
13. Reriani MK, Lerman LO, Lerman A. Endothelial function as a functional expression of cardiovascular risk factors. Biomark Med 2010; 4: 351-360.
14. Kinlay S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol 1997; 80: 11I-16I.
15. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-175.
16. el-Tamimi H, Mansour M, Wargovich TJ, Hill JA, Kerensky RA, Conti CR, et al. Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease: Endothelial function revisited. Circulation 1994; 89: 45-51.
17. el-Tamimi H, Mansour M, Pepine CJ, Wargovich TJ, Chen H. Circadian variation in coronary tone in patients with stable angina. Protective role of the endothelium. Circulation 1995; 92: 3201-3205.
18. Kuga T, Egashira K, Mohri M, Tsutsui H, Harasawa Y, Urabe Y, et al. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. Circulation 1995; 92: 183-189.
19. Lerman A, Burnett JC Jr. Intact and altered endothelium in regulation of vasomotion. Circulation 1992; 86: III12-III19.
20. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347: 5-12.
21. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011; 364: 226-235.
22. Lavi S, Bae JH, Rihal CS, Prasad A, Barsness GW, Lennon RJ, et al. Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart 2009; 95: 1525-1530.
23. Lerman A, Holmes DR, Herrmann J, Gersh BJ. Microcirculatory dysfunction in st-elevation myocardial infarction: Cause, consequence, or both? Eur Heart J 2007; 28: 788-797.
24. Gibson CM, Kirtane AJ, Morrow DA, Palabrica TM, Murphy SA, Stone PH, et al. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate-to high-risk acute coronary syndromes: Observations from the randomized trial to evaluate the relative protection against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (Protect-TIMI 30). Am Heart J 2006; 152: 756-761.
25. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-954.
26. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-1906.
27. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-196.
28. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
29. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation 2005; 111: 363-368.
30. Jiang W, Babyak M, Krantz DS, Waugh RA, Coleman RE, Hanson MM, et al. Mental stress: Induced myocardial ischemia and cardiac events. JAMA 1996; 275: 1651-1656.
31. Redberg RF, Cannon RO 3rd, Bairey Merz N, Lerman A, Reis SE, Sheps DS. Women's ischemic syndrome evaluation: Current status and future research directions. Report of the national heart, lung and blood institute workshop, October 2-4, 2002; Section 2: Stable ischemia: Pathophysiology and gender differences. Circulation 2004; 109: e47-e49.
32. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192-2217.
33. Strike PC, Steptoe A. Systematic review of mental stress-induced myocardial ischaemia. Eur Heart J 2003; 24: 690-703.
34. Gottdiener JS, Kop WJ, Hausner E, McCeney MK, Herrington D, Krantz DS. Effects of mental stress on flow-mediated brachial arterial dilation and influence of behavioral factors and hypercholesterolemia in subjects without cardiovascular disease. Am J Cardiol 2003; 92: 687-691.
35. Spieker LE, Hurlimann D, Ruschitzka F, Corti R, Enseleit F, Shaw S, et al. Mental stress induces prolonged endothelial dysfunction via endothelin-a receptors. Circulation 2002; 105: 2817-2820.
36. Ghiadoni L, Donald AE, Cropley M, Mullen MJ, Oakley G, Taylor M, et al. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000; 102: 2473-2478.
37. Harris CW, Edwards JL, Baruch A, Riley WA, Pusser BE, Rejeski WJ, et al. Effects of mental stress on brachial artery flow-mediated vasodilation in healthy normal individuals. Am Heart J 2000; 139: 405-411.
38. Cardillo C, Kilcoyne CM, Cannon RO 3rd, Panza JA. Impairment of the nitric oxide-mediated vasodilator response to mental stress in hypertensive but not in hypercholesterolemic patients. J Am Coll Cardiol 1998; 32: 1207-1213.
39. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ Jr, Ganz P, et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991; 325: 1551-1556.
40. Ramachandruni S, Fillingim RB, McGorray SP, Schmalfuss CM, Cooper GR, Schofield RS, et al. Mental stress provokes ischemia in coronary artery disease subjects without exercise-or adenosine-induced ischemia. J Am Coll Cardiol 2006; 47: 987-991.
41. Rozanski A, Bairey CN, Krantz DS, Friedman J, Resser KJ, Morell M, et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med 1988; 318: 1005-1012.
42. Deanfield JE, Shea M, Kensett M, Horlock P, Wilson RA, de Landsheere CM, et al. Silent myocardial ischaemia due to mental stress. Lancet 1984; 2: 1001-1005.
43. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med 1996; 334: 413-419.
44. Blumenthal JA, Jiang W, Waugh RA, Frid DJ, Morris JJ, Coleman RE, et al. Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life: Association and hemodynamic features. Circulation 1995; 92: 2102-2108.
45. Trichopoulos D, Katsouyanni K, Zavitsanos X, Tzonou A, Dalla-Vorgia P. Psychological stress and fatal heart attack: The Athens (1981) earthquake natural experiment. Lancet 1983; 1: 441-444.
46. Meisel SR, Kutz I, Dayan KI, Pauzner H, Chetboun I, Arbel Y, et al. Effect of iraqi missile war on incidence of acute myocardial infarction and sudden death in israeli civilians. Lancet 1991; 338: 660-661.
47. Witte DR, Bots ML, Hoes AW, Grobbee DE. Cardiovascular mortality in Dutch men during 1996 European football championship: Longitudinal population study. BMJ 2000; 321: 1552-1554.
48. Kuroda T, Kuwabara Y, Watanabe S, Nakaya J, Hasegawa R, Shikama T, et al. Effect of mental stress on left ventricular ejection fraction and its relationship to the severity of coronary artery disease. Eur J Nucl Med 2000; 27: 1760-1767.
49. Lavie P, Shlitner A, Sheffy J, Schnall RP. Peripheral arterial tonometry: A novel and sensitive non-invasive monitor of brief arousals during sleep. Isr Med Assoc J 2000; 2: 246-247.
50. Martin EA, Prasad A, Rihal CS, Lerman LO, Lerman A. Endothelial function and vascular response to mental stress are impaired in patients with apical ballooning syndrome. J Am Coll Cardiol 2010; 56: 1840-1846.
51. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
52. Laaban JP, Pascal-Sebaoun S, Bloch E, Orvoen-Frija E, Oppert JM, Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 2002; 122: 1133-1138.
53. Olson LG, King MT, Hensley MJ, Saunders NA. A community study of snoring and sleep-disordered breathing: Health outcomes. Am J Respir Crit Care Med 1995; 152: 717-720.
54. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: A long-term follow-up. Eur Respir J 2006; 28: 596-602.
55. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990; 336: 261-264.
56. Baldwin CM, Bell IR, Guerra S, Quan SF. Obstructive sleep apnea and ischemic heart disease in southwestern US veterans: Implications for clinical practice. Sleep Breath 2005; 9: 111-118.
57. Hayashi M, Fujimoto K, Urushibata K, Uchikawa S, Imamura H, Kubo K. Nocturnal oxygen desaturation correlates with the severity of coronary atherosclerosis in coronary artery disease. Chest 2003; 124: 936-941.
58. Mohsenin V. Is sleep apnea a risk factor for stroke? A critical analysis. Minerva Med 2004; 95: 291-305.
59. Neau JP. Vascular disorders and obstructive sleep apnea syndrome. Rev Neurol (Paris) 2001; 157: S34-S37 (in French).
60. Parra O, Arboix A, Montserrat JM, Quinto L, Bechich S, Garcia-Eroles L. Sleep-related breathing disorders: Impact on mortality of cerebrovascular disease. Eur Respir J 2004; 24: 267-272.
61. Schulz R, Olschewski H, Grimminger F, Seeger W. Prevalence of stroke and transitory ischemic attacks in obstructive sleep apnea: A retrospective analysis of 187 consecutive patients. Pneumologie 2000; 54: 575-579 (in German).
62. Schulz R, Seeger W, Fegbeutel C, Husken H, Bodeker RH, Tillmanns H, et al. Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 2005; 25: 69-74.
63. Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A. Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol 2007; 50: 1310-1314.
64. Atkeson A, Yeh SY, Malhotra A, Jelic S. Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis 2009; 51: 351-362.
65. Kohler M, Craig S, Nicoll D, Leeson P, Davies RJO, Stradling JR. Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med 2008; 178: 984-988.
66. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008; 117: 2270-2278.
67. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169: 348-353.
68. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, Fujioka D, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 2009; 53: 323-330.
69. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40: 505-510.
70. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502-509.
71. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003; 146: 168-174.
72. Kuvin JT, Mammen A, Mooney P, Alsheikh-Ali AA, Karas RH. Assessment of peripheral vascular endothelial function in the ambulatory setting. Vasc Med 2007; 12: 13-16.
73. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 2006; 101: 545-548.
74. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 2002; 105: 1567-1572.
75. Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004; 44: 2137-2141.
76. Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham heart study. Circulation 2008; 117: 2467-2474.
77. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010; 31: 1142-1148.
78. Krantz DS, Santiago HT, Kop WJ, Bairey Merz CN, Rozanski A, Gottdiener JS. Prognostic value of mental stress testing in coronary artery disease. Am J Cardiol 1999; 84: 1292-1297.
79. Goldberg AD, Becker LC, Bonsall R, Cohen JD, Ketterer MW, Kaufman PG, et al. Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress: Experience from the Psychophysiological Investigations of Myocardial Ischemia study (PIMI). Circulation 1996; 94: 2402-2409.
80. Goor DA, Sheffy J, Schnall RP, Arditti A, Caspi A, Bragdon EE, et al. Peripheral arterial tonometry: A diagnostic method for detection of myocardial ischemia induced during mental stress tests: A pilot study. Clin Cardiol 2004; 27: 137-141.
81. Ueyama T, Senba E, Kasamatsu K, Hano T, Yamamoto K, Nishio I, et al. Molecular mechanism of emotional stress-induced and catecholamine-induced heart attack. J Cardiovasc Pharmacol 2003; 41(Suppl 1): S115-S118.
82. Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, et al. Transient left ventricular apical ballooning without coronary artery stenosis: A novel heart syndrome mimicking acute myocardial infarction. Angina pectoris-myocardial infarction investigations in japan. J Am Coll Cardiol 2001; 38: 11-18.
83. Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol 2007; 50: 448-452.